Morepen Laboratories Results Update

Morepen Laboratories Management Change

Morepen Laboratories announced promotions effective 27 October 2026 for two senior management personnel. Charanjeet Chitakara moves to Assistant Vice President (Quality Control) and Vivan Prashar to Vice President (Projects & Engineering).

Morepen Laboratories Other Announcement

Morepen filed its Q2FY27 Monitoring Agency Report confirming Nil deviation in QIP proceeds utilization. The company spent ₹1.12 crore on modernization and expansion during the quarter.

Morepen Laboratories Investor Presentation: Key Takeaways

Q2 FY27 revenue Rs755 Cr (+81%), PAT Rs89 Cr (+117%), EBITDA margin 17.45% (+897bps). H1 revenue Rs1,330 Cr (+57%). CDMO scale-up drives mix.

Morepen Laboratories Results Update

Morepen hit record Q2 FY27 revenue up 81% and EBITDA up 273%, driven by CDMO scale-up. H1 EBITDA reached ₹220 Cr; API+CDMO capacity now 614 KL.

API + CDMO manufacturing capacity

614 KL

Morepen Laboratories Q2 FY27 Results: Net Profit ₹88.9 Cr, Up 117.4% YoY

Morepen Laboratories Ltd reported revenue from operations of ₹746.5 Cr (+81.4% YoY) and net profit of ₹88.9 Cr (+117.4% YoY) for Q2 FY27.

Key figure

Net profit ₹88.9 Cr · +117.4% YoY

Morepen Laboratories Board Meeting Date

Morepen Laboratories Limited announced a board meeting scheduled for October 27, 2026. The meeting will consider and approve the financial results for the quarter ended September 30, 2026.

Wheels India Results Update

Wheels India reported Q2 FY27 net profit of ₹53.4 Crore and revenue of ₹1,598 Crore, up 36% YoY. The company completed a ₹430 Crore fund raise.

Ambuja Cements Results Update

Ambuja Cements posted Q2 FY27 consolidated revenue of Rs 9,197 Cr with EBITDA of Rs 1,271 Cr. The firm commissioned 4.6 MTPA of new capacity amid headwinds.

cement manufacturing capacity

4.6 MTPA

Vishal Nirmiti Results Update

Vishal Nirmiti reported Q1 FY27 revenue of ₹869.7 Cr (up 35%) and PAT of ₹68.8 Cr. Order book stands at ₹5,516.7 Cr.

GK Energy Results Update

GK Energy reported Q2 FY27 revenue of ₹402.65 Crore and PAT of ₹49.36 Crore with 19,391 systems installed. H1 FY27 PAT grew 30.7% Y-o-Y to ₹109.04 Crore.

Shadowfax Technologies Results Update

Shadowfax reported Q2 FY27 revenue of ₹1,538 Cr, up 56.6% YoY, with PAT at ₹68 Cr. Sixth consecutive 55%+ growth quarter, Adj. EBITDA margin at 5.0%.

Senores Pharmaceuticals Results Update

Senores reported Q2 FY27 revenue of ₹192 cr and EBITDA of ₹58 cr, both record highs. PAT grew 22% Y-o-Y to ₹37 cr with positive FY27 outlook.